Mesenchymal Stromal Cell Derived Extracellular Vesicles Reduce Hypoxia-Ischaemia Induced Perinatal Brain Injury

Background Neonatal hypoxic-ischemic (HI) insult is a leading cause of disability and death in newborns, with therapeutic hypothermia being the only currently available clinical intervention. Thus there is a great need for adjunct and novel treatments for enhanced or alternative post-HI neuroprotection. Extracellular vesicles (EVs) derived from mesenchymal stromal/stem cells (MSCs) have recently been shown to exhibit regenerative effects in various injury models. Here we present findings showing neuroprotective effects of MSC-derived EVs in the Rice–Vannucci model of severe HI-induced neonatal brain insult. Methods Mesenchymal stromal/stem cell-derived EVs were applied intranasally immediately post HI-insult and behavioral outcomes were observed 48 h following MSC-EV treatment, as assessed by negative geotaxis. Brains were thereafter excised and assessed for changes in glial responses, cell death, and neuronal loss as markers of damage at 48 h post HI-insult. Results Brains of the MSC-EV treated group showed a significant decrease in microglial activation, cell death, and percentage tissue volume loss in multiple brain regions, compared to the control-treated groups. Furthermore, negative geotaxis test showed improved behavioral outcomes at 48 h following MSC-EV treatment. Conclusion Our findings highlight the clinical potential of using MSC-derived EVs following neonatal hypoxia-ischaemia.

[1]  D. Peebles,et al.  Extracellular signal‐regulated kinase 2 has duality in function between neuronal and astrocyte expression following neonatal hypoxic–ischaemic cerebral injury , 2018, The Journal of physiology.

[2]  D. Peebles,et al.  The duration of hypothermia affects short-term neuroprotection in a mouse model of neonatal hypoxic ischaemic injury , 2018, PloS one.

[3]  Y. Chang,et al.  Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy , 2018, Scientific reports.

[4]  P. Gressens,et al.  Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+CD90+CD105+ amniotic fluid stem cells , 2018, Scientific Reports.

[5]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[6]  P. Quesenberry,et al.  Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells , 2017, Tissue engineering. Part A.

[7]  D. Prockop,et al.  Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus , 2017, Proceedings of the National Academy of Sciences.

[8]  S. Lim,et al.  Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. , 2016, Osteoarthritis and cartilage.

[9]  M. Brizzi,et al.  Extracellular vesicles as new players in angiogenesis. , 2016, Vascular pharmacology.

[10]  James W. Clancy,et al.  Biology and biogenesis of shed microvesicles , 2016, Small GTPases.

[11]  Y. Chang,et al.  Stem Cells for Neonatal Brain Disorders , 2016, Neonatology.

[12]  Reint K Jellema,et al.  Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia‐Ischemia , 2016, Stem cells translational medicine.

[13]  P. Quesenberry,et al.  Mesenchymal stromal cell derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells , 2016, Leukemia.

[14]  E. Rocha-Ferreira,et al.  Plasticity in the Neonatal Brain following Hypoxic-Ischaemic Injury , 2016, Neural plasticity.

[15]  A. Herbison,et al.  Hypothalamic control of the male neonatal testosterone surge , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  C. Aguayo,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application , 2016, Front. Physiol..

[17]  D. Peebles,et al.  Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) reduces neonatal hypoxic‐ischaemic brain damage , 2016, Journal of neurochemistry.

[18]  D. Peebles,et al.  The role of different strain backgrounds in bacterial endotoxin-mediated sensitization to neonatal hypoxic–ischemic brain damage , 2015, Neuroscience.

[19]  R. Schmidt-Kastner,et al.  Genomic approach to selective vulnerability of the hippocampus in brain ischemia–hypoxia , 2015, Neuroscience.

[20]  C. Mallard,et al.  Modeling Ischemia in the Immature Brain: How Translational Are Animal Models? , 2015, Stroke.

[21]  M. Wood,et al.  Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. , 2015, Human gene therapy.

[22]  P. Provero,et al.  AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs. , 2015, Journal of the American Society of Nephrology : JASN.

[23]  Hye Soo Yoo,et al.  Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy , 2015, PloS one.

[24]  Steven M Jay,et al.  Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. , 2015, Tissue engineering. Part B, Reviews.

[25]  Joshua N Leonard,et al.  Therapeutic applications of extracellular vesicles: clinical promise and open questions. , 2015, Annual review of pharmacology and toxicology.

[26]  Y. Mo,et al.  Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites , 2014, Oncotarget.

[27]  R. Dijkhuizen,et al.  Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury , 2014, Experimental Neurology.

[28]  M. Madrigal,et al.  A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods , 2014, Journal of Translational Medicine.

[29]  D. Stepensky,et al.  Quantitative analysis of drug delivery to the brain via nasal route. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[30]  P. Djupesland,et al.  The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. , 2014, Therapeutic delivery.

[31]  N. Marlow,et al.  Effects of hypothermia for perinatal asphyxia on childhood outcomes. , 2014, The New England journal of medicine.

[32]  S. Lim,et al.  Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models , 2014, Stem Cell Research & Therapy.

[33]  D. Peebles,et al.  Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates , 2014, Journal of neurochemistry.

[34]  J. Houtgraaf,et al.  Intracoronary Stem Cell Infusion After Acute Myocardial Infarction: A Meta-Analysis and Update on Clinical Trials , 2014, Circulation. Cardiovascular interventions.

[35]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[36]  Gerry Leisman,et al.  Cognitive-motor interactions of the basal ganglia in development , 2014, Front. Syst. Neurosci..

[37]  R. Fitch,et al.  Behavioral and histological outcomes following neonatal HI injury in a preterm (P3) and term (P7) rodent model , 2014, Behavioural Brain Research.

[38]  N. Robertson,et al.  Na+/H+ Exchangers and Intracellular pH in Perinatal Brain Injury , 2014, Translational Stroke Research.

[39]  T. Vos,et al.  Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990 , 2013, Pediatric Research.

[40]  S. Pluchino,et al.  The stem cell secretome and its role in brain repair , 2013, Biochimie.

[41]  C. Netto,et al.  Early hypoxia–ischemia causes hemisphere and sex-dependent cognitive impairment and histological damage , 2013, Neuroscience.

[42]  J. Fine,et al.  Intranasal administration of CNS therapeutics to awake mice. , 2013, Journal of visualized experiments : JoVE.

[43]  S. Lim,et al.  Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. , 2013, Advanced drug delivery reviews.

[44]  P. Davis,et al.  Cooling for newborns with hypoxic ischaemic encephalopathy. , 2013, The Cochrane database of systematic reviews.

[45]  K. English.  Mechanisms of mesenchymal stromal cell immunomodulation , 2013, Immunology and cell biology.

[46]  Changjin Lee,et al.  Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension , 2012, Circulation.

[47]  J. Volpe,et al.  Neonatal encephalopathy: An inadequate term for hypoxic–ischemic encephalopathy , 2012, Annals of neurology.

[48]  Y. Chang,et al.  Human umbilical cord blood–derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats , 2012, Pediatric Research.

[49]  B. Vohr,et al.  Childhood outcomes after hypothermia for neonatal encephalopathy. , 2012, The New England journal of medicine.

[50]  Z. Han,et al.  [Effects of interferon-γ on biological characteristics and immunomodulatory property of human umbilical cord-derived mesenchymal stem cells]. , 2012, Zhongguo shi yan xue ye xue za zhi.

[51]  G. Camussi,et al.  Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury , 2012, PloS one.

[52]  S. Kang,et al.  Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells , 2012, Journal of veterinary science.

[53]  D. Peebles,et al.  Distribution of pH Changes in Mouse Neonatal Hypoxic-Ischaemic Insult , 2012, Developmental Neuroscience.

[54]  A. Kavelaars,et al.  Mesenchymal stem cells as a treatment for neonatal ischemic brain damage , 2012, Pediatric Research.

[55]  Wenyu Lin,et al.  Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. , 2012, Cytotherapy.

[56]  J. Inal,et al.  Microvesicles in Health and Disease , 2012, Archivum Immunologiae et Therapiae Experimentalis.

[57]  G. Camussi,et al.  Endothelial Progenitor Cell-Derived Microvesicles Improve Neovascularization in a Murine Model of Hindlimb Ischemia , 2012, International journal of immunopathology and pharmacology.

[58]  Kullervo Hynynen,et al.  Targeted Delivery of Neural Stem Cells to the Brain Using MRI-Guided Focused Ultrasound to Disrupt the Blood-Brain Barrier , 2011, PloS one.

[59]  J. Allsop,et al.  Predicting motor outcome and death in term hypoxic-ischemic encephalopathy , 2011, Neurology.

[60]  G. Camussi,et al.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[61]  D. Peebles,et al.  TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult , 2011, Laboratory Investigation.

[62]  Kazuo Suzuki,et al.  Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO) , 2011, PloS one.

[63]  S. Gambhir,et al.  Biodistribution of Neural Stem Cells After Intravascular Therapy for Hypoxic–Ischemia , 2010, Stroke.

[64]  Nadia Badawi,et al.  Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. , 2010, Early human development.

[65]  M. Chopp,et al.  Effects of Administration Route on Migration and Distribution of Neural Progenitor Cells Transplanted into Rats with Focal Cerebral Ischemia, an MRI Study , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[66]  Frank van Bel,et al.  Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration , 2010, Brain, Behavior, and Immunity.

[67]  G. Camussi,et al.  Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information , 2010, Current opinion in nephrology and hypertension.

[68]  H. Ozkan,et al.  Role of epigenetic regulatory mechanisms in neonatal hypoxic-ischemic brain injury. , 2009, Early human development.

[69]  S. Savitz,et al.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. , 2009, Stem cells and development.

[70]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[71]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[72]  T. Suuronen,et al.  The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats , 2008, Neuroscience Letters.

[73]  M. Pittenger,et al.  Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia , 2008, Stroke.

[74]  J. Yi,et al.  Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage , 2007, Neurochemistry International.

[75]  A. Edwards,et al.  Deletion of the c-Jun N-terminal Kinase 3 Gene Protects Neonatal Mice against Cerebral Hypoxic—Ischaemic Injury , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[76]  Andrew Whitelaw,et al.  Determinants of Outcomes After Head Cooling for Neonatal Encephalopathy , 2007, Pediatrics.

[77]  T. Herdegen,et al.  PPAR-γ: therapeutic target for ischemic stroke , 2007 .

[78]  J. Perlman,et al.  Intervention strategies for neonatal hypoxic-ischemic cerebral injury. , 2006, Clinical therapeutics.

[79]  M. Mishkin,et al.  Brain and cognitive-behavioural development after asphyxia at term birth. , 2006, Developmental science.

[80]  O. Iwata,et al.  N-Methyl-isobutyl-amiloride Ameliorates Brain Injury When Commenced Before Hypoxia Ischemia in Neonatal Mice , 2006, Pediatric Research.

[81]  G. Aylward,et al.  Neurodevelopmental Outcomes of Infants Born Prematurely , 2005, Journal of developmental and behavioral pediatrics : JDBP.

[82]  A. Tamas,et al.  Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury , 2005, Behavioural Brain Research.

[83]  C. Petten.  Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis , 2004, Neuropsychologia.

[84]  Roland Meisel,et al.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. , 2004, Blood.

[85]  C. Shatz,et al.  Selective Vulnerability of Subplate Neurons after Early Neonatal Hypoxia-Ischemia , 2003, The Journal of Neuroscience.

[86]  D. Peebles,et al.  White Matter Injury Following Systemic Endotoxemia or Asphyxia in the Fetal Sheep , 2003, Neurochemical Research.

[87]  M. Johnston,et al.  Mechanisms of Hypoxic Neurodegeneration in the Developing Brain , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[88]  R. J. McDonald,et al.  Multiple Parallel Memory Systems in the Brain of the Rat , 2002, Neurobiology of Learning and Memory.

[89]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[90]  A. Majnemer,et al.  Topical Review: Long-Term Developmental Outcome of Asphyxiated Term Neonates , 2001, Journal of child neurology.

[91]  Akira Ishida,et al.  The Developing Nervous System: A Series of Review Articles: Neurobiology of Hypoxic-Ischemic Injury in the Developing Brain , 2001, Pediatric Research.

[92]  J. Volpe,et al.  Perinatal brain injury: from pathogenesis to neuroprotection. , 2001, Mental retardation and developmental disabilities research reviews.

[93]  T. Ikeda,et al.  Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats , 2001, Behavioural Brain Research.

[94]  Yvonne W Wu,et al.  Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. , 2000, JAMA.

[95]  B. Vohr,et al.  Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. , 2000, Pediatrics.

[96]  S. Wolfensohn,et al.  Quantitative assessment of welfare in experimental animals: the development and use of scoring systems , 1999 .

[97]  R. Vannucci,et al.  A model of Perinatal Hypoxic‐Ischemic Brain Damage a , 1997, Annals of the New York Academy of Sciences.

[98]  A. Brambrink,et al.  Primary sensory and forebrain motor systems in the newborn brain are preferentially damaged by hypoxia‐ischemia , 1997, The Journal of comparative neurology.

[99]  H. Lou,et al.  Etiology and pathogenesis of Attention‐deficit Hyperactivity Disorder (ADHD): significance of prematurity and perinatal hypoxic‐haemodynamic encephalopathy , 1996, Acta paediatrica.

[100]  J. D. McGaugh,et al.  Inactivation of Hippocampus or Caudate Nucleus with Lidocaine Differentially Affects Expression of Place and Response Learning , 1996, Neurobiology of Learning and Memory.

[101]  D. Aram,et al.  The Effect of Very Low Birth Weight and Social Risk on Neurocognitive Abilities at School Age , 1992, Journal of developmental and behavioral pediatrics : JDBP.

[102]  G. Delong,et al.  Autism, amnesia, hippocampus, and learning , 1992, Neuroscience & Biobehavioral Reviews.

[103]  A. Kaštelan,et al.  [The regulation of immune responses]. , 1983, Lijecnicki vjesnik.

[104]  L. V. Marter.  Childhood Outcomes after Hypothermia for Neonatal Encephalopathy , 2012 .

[105]  D. Prockop,et al.  Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[106]  D. Peebles,et al.  Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development , 2010, Glia.

[107]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[108]  M. Castillo.  Selective vulnerability and the cerebellum in neonates. , 2007, AJNR. American journal of neuroradiology.

[109]  F. Merkus,et al.  Can Nasal Drug Delivery Bypass the Blood-Brain Barrier? , 2007, Drugs in R&D.

[110]  E. Bouhassira,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2007 .

[111]  BMC Neuroscience BioMed Central Review , 2006 .

[112]  G. Cioni,et al.  Neonatal cerebral infarction and neuromotor outcome at school age. , 2004, Pediatrics.

[113]  E. Mercuri,et al.  Neonatal Brain MRI and Motor Outcome at School Age in Children with Neonatal Encephalopathy: A Review of Personal Experience , 2003, Neural plasticity.

[114]  B. Knowlton,et al.  Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.

[115]  D. Peebles,et al.  Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. , 2002, Mental retardation and developmental disabilities research reviews.

[116]  D. Vigneron,et al.  Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. , 1998, AJNR. American journal of neuroradiology.

[117]  M. Roth.  A quantitative assessment , 1987 .

[118]  J. R.,et al.  Quantitative analysis , 1892, Nature.